Last week, the task force assembled by Justin Trudeau’s Liberal government to assess the prospect of cannabis legalization released its recommendations. Among the 80 items outlined in the document, a minimum age for consumption of 18, tight controls on advertising and a personal possession limit of 30 grams were highlighted as suggestions to help facilitate the future recreational market.
For the country’s medical patients, the document translated to early good news. While many industry insiders had speculated a move to marry the medical and recreational markets, the task force recommended the integrity of the ACMPR be protected when reform is welcomed. In other words, when Canada’s legal industry comes into effect, the task force is encouraging the government preserve the enshrined rights of medical marijuana users.
“During our consultations, we heard many compelling personal stories of how cannabis is making a difference to Canadians living with serious health challenges such as cancer, HIV/AIDS, multiple sclerosis, arthritis and fibromyalgia,” the task force reported. “We also heard about the role that cannabis can play in pain management and palliative care, and the relief that cannabis, particularly strains with high levels of CBD and low levels of THC, offers to children with severe forms of epilepsy.”